Answers are grounded in this paper and cite their sources.
Background: despite recent advances in understanding the pathobiology of systemic sclerosis (SSc), cardio-vascular burden remains a challenge in daily practice. Echocardiography emerges as a valuable non-invasive technique extensively recommended for the screening, evaluation and monitoring of cardiac involvement (CI) in different SSc settings. Objectives: the main aim of this study was to evaluate the prevalence and the type of cardiac involvement (clinical/subclinical; primary/secondary) in SSc and to identify potential relation with disease subsets, activity and severity. Methods: cross-sectional study in 665 consecutive SSc (fulfilling 2013 ACR/EULAR classification, attending the outpatient rheumatology at least once. Patients were assessed according to a standardized protocol comprising demographics, SSc-related clinical and immunologic parameters, disease activity and severity; cardiac involvement (systolic and diastolic dysfunction, pericardial disease, myocardial ischemia, pulmonary hypertension, valve damage) was evaluated by 2D transthoracic Doppler-echocardiography (TTE). Statistical analysis was done in GraphPad Prism 8, p<0.05. Results: CI was detected in 296 SSc (44,6%) patients with diffuse cutaneous (dcSSc) developing earlier CI compared with limited (lcSSc) (p<0.05). Asymptomatic left ventricular dysfunction was described in 15,38%, while important decrease in ejection fraction (LVEF) (as low as 30%) in 6.15%, with a statistically significant negative correlation with disease duration and activity (p<0.05). Diastolic dysfunction was registered in 46,15% SSc with a direct correlation with disease duration and age (p<0.05) Myocardial fibrosis in a mosaic patchy distribution was reported in up one third SSc, while cardiomyopathy in limited cases. Mild pericardial effusion was observed in 24,61 % patients more frequent in dcSSc (p<0.05), while cardiac tamponade in only one case. Valvular disease was uncommon in SSc, reported only in 2,2% (mitral valve prolapse). Abnormal systolic pressure in pulmonary artery (sPAP) was found in 14,89% SSc, particularly in lcSSc, associated right atrial (15,1%) or ventricular (20.2%) enlargement. Anticentromere positivity, older age at first non RP symptom, digital ulcer, and severe joint involvement were associated with high sPAP (<0.05). Conclusion: Patients with SSc (diffuse or limited) are at increased risk of developing either clinical or subclinical cardiovascular manifestations as demonstrated by echocardiographic studies. A systematic TTE assessment is routinely recommended for the screening and monitoring of cardiac events. REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests: None declared.
No takes yet. Share an insight, caveat, or question.
Perretta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: